Atypical bilateral papilledema during the puerperium: a case report

Ligang Jiang1, Xin Jiang2, Ailian Li1

  • 1Department of Ophthalmology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.

Frontiers in Medicine
|July 21, 2025
PubMed

Insights

This case highlights atypical postpartum vision loss due to bilateral papilledema. Prompt diagnosis and intervention for increased intracranial pressure, considering multiple risk factors, are crucial for recovery.

Area of Science:

  • Ophthalmology
  • Neurology
  • Obstetrics

Background:

  • Puerperium presents unique physiological challenges, including hypercoagulable states and immune alterations, which can contribute to neurological complications.
  • Atypical bilateral papilledema in the postpartum period requires thorough investigation beyond typical symptoms like headache or dizziness.

Observation:

  • A 28-year-old woman with a history of low BMI, cesarean section, and prior venous thrombosis developed decreased vision and bilateral papilledema.
  • Clinical findings included elevated D-dimer, abnormal immune indicators, optic nerve sheath widening on ultrasound, and venous sinus stenosis on MRV.
  • The patient presented without classic symptoms of increased intracranial pressure, such as headache or tinnitus.

Findings:

  • Multifactorial intracranial hypertension was diagnosed, involving venous sinus stenosis, hypercoagulability, and potential immune dysregulation.
  • Ocular findings of bilateral papilledema and right macular edema improved with treatment including mannitol and anticoagulation.
  • Ocular ultrasound proved useful in detecting optic nerve sheath widening, indicative of elevated intracranial pressure.

Implications:

  • This case underscores the importance of considering multiple pathogenic factors in postpartum women with atypical bilateral papilledema.
  • Imaging of intracranial venous sinuses and immune marker screening are recommended for early diagnosis.
  • Ocular ultrasound serves as a valuable, non-invasive tool for screening intracranial hypertension in this population.
Abstract